Holding the Line for Pet Safety: Inside the Ongoing Battle Over FDA Accountability in Pet Food Regulation

By Investigative Reporting Desk
Published: September 2026

Main Facts: The Growing Transparency Crisis at the FDA’s Center for Veterinary Medicine

For millions of pet owners, commercial pet food is accepted as a safe, regulated product backed by rigorous federal oversight. Consumers trust that the labels on bags of kibble and cans of wet food tell the whole truth, that manufacturing standards are strictly enforced, and that public health warnings are issued transparently and comprehensively.

However, behind the scenes, consumer advocacy organizations paint a starkly different picture—one characterized by regulatory inertia, unreturned communications, and a systemic failure to enforce federal statutes.

At the center of this accountability battle is TruthaboutPetFood.com and its founder, pet food consumer advocate Susan Thixton. For years, Thixton and the Association for Truth in Pet Food have pressed the U.S. Food and Drug Administration (FDA) and its Center for Veterinary Medicine (CVM) to answer fundamental questions regarding pet food labeling laws, ingredient transparency, public health safety alerts regarding avian flu, and the future of industry modernization.

The core issue is not merely bureaucratic sluggishness; it touches upon the fundamental enforcement of the Federal Food, Drug, and Cosmetic Act (FD&C Act). According to the FDA’s own published mandate, the FD&C Act requires that all animal foods, much like human foods, must be safe to eat, produced under sanitary conditions, free of harmful substances, and truthfully labeled.

Yet, a mounting backlog of unanswered inquiries, delayed formal petitions, and deflected questions suggests that federal oversight of the multi-billion-dollar pet food industry may be suffering from a profound lack of active enforcement. From misleading product packaging featuring whole cuts of fresh meat on bags of meal-based kibble to opaque risk-reporting surrounding feline health threats, the regulatory gap between statutory law and everyday market reality is widening.

Chronology: A Timeline of Unanswered Inquiries and Regulatory Delays

The friction between pet food advocates and federal regulators is best understood through a chronological examination of specific inquiries submitted to the CVM. Despite statutory expectations of transparent agency communication, a pattern of silence and delayed responses has defined the relationship.

2022: The Citizen Petition

• July 2022: Thixton files an official Citizen Petition with the FDA, explicitly requesting that the agency abide by federal law in regulating misleading pet food ingredient names and labeling practices. Under federal guidelines, the agency is legally mandated to provide a substantive response within 180 days.
• The Delay: The FDA misses the 180-day window by years.
• The Resolution (1,333 Days Later): After a staggering 1,333 days of waiting, the FDA formally responds, issuing a definitive refusal to enforce the requested statutory interpretations regarding pet food labeling transparency.

May – June 2025: The AAFCO Modernization Disconnect

• May 29, 2025: Following the FDA’s decision to end its long-standing relationship with the Association of American Feed Control Officials (AAFCO), advocates ask the CVM whether the widely discussed AAFCO Pet Food Label Modernization updates will still be recognized or implemented by the federal agency.
• June 2025: CVM replies within a week, but instead of answering the direct question, the agency merely points stakeholders to a general acknowledgment letter regarding the expiring FDA-AAFCO Memorandum of Understanding (MOU).
• June 5, 2025: A direct follow-up email points out that the linked document contains zero information regarding label modernization, re-asking if the changes will be implemented.
• The Outcome: A subsequent CVM reply offers no new information, simply telling the petitioner to refer to the previous—and irrelevant—response.

September 2025: Avian Flu Risk Inquiries

• September 15, 2025: Citing public health concerns, advocates submit urgent questions regarding the FDA’s communication strategy surrounding Highly Pathogenic Avian Influenza (HPAI) risks. While the FDA issues numerous public safety alerts warning consumers exclusively about raw pet food, USDA statistics show that diagnosed raw-fed cats make up only 4% of total domestic cat cases since May 2022. Advocates press the agency on the remaining 96% of cases (dietary styles, indoor vs. outdoor status) and ask whether withholding this data constitutes public health negligence.
• The Outcome: The FDA provides no response to these questions.

January – September 2026: The Meow Mix Labeling Inquiry

• January 28, 2026: Advocates submit a formal inquiry to the FDA highlighting a prominent commercial product: Meow Mix Original Choice Cat Food. The packaging prominently displays high-resolution images of a grilled piece of chicken breast, a roasted turkey slice, and two fresh fish fillets. However, the ingredient list reveals that the food is manufactured using processed meal ingredients (chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal). The FDA is asked to explain how this aligns with the FD&C Act’s "truthfully labeled" mandate.
• March 12, 2026: With zero response received, a follow-up message is sent to CVM requesting either an answer or an explanation for the agency’s silence.
• September 15, 2026: Months pass with total silence from federal regulators.

July 2026: Slaughterhouse "Tankage" and Ingredient Nomenclature

• July 6, 2026: Advocates query the FDA regarding slaughterhouse "tankage"—condemned materials processed in USDA slaughter facilities. The question asks how this material is legally required to be identified to consumers on pet food labels (e.g., whether tankage derived from a USDA chicken facility must be labeled as "chicken" or "chicken meal").
• The Outcome: The FDA leaves the question entirely unanswered.

April – September 2026: The Petition for Reconsideration

• April 13, 2026: Following the FDA’s rejection of the 2022 Citizen Petition, advocates file a formal Petition for Reconsideration, supplying new evidence of consumer deception driven by a lack of label enforcement, and requesting a decision within 45 days.
• September 15, 2026: 155 days elapse with no acknowledgment or decision rendered by the agency.

Supporting Data: Dissecting the Transparency Gap

To evaluate the validity of these consumer grievances, one must examine the specific data points driving the conflict between regulatory theory and market reality.

1. Label Imagery vs. Ingredient Reality

Federal statutes dictate that food labeling must not be false or misleading. In human food regulation, depicting raw, whole cuts of meat on a package when the contents consist entirely of rendered meals or by-product meals would invite swift regulatory scrutiny. Yet, in the pet food aisle, packaging like that found on Meow Mix Original Choice routinely features idealized photography of fresh chicken breasts, whole turkeys, and whole fish fillets.

When parsed against the actual ingredient panel—which lists chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal—a clear dichotomy emerges. Meals and by-products are highly processed, rendered commodities fundamentally different in physical form and consumer perception from the whole meats depicted on the box. By refusing to address inquiries on this practice, critics argue the FDA tacitly permits visual marketing that misleads average pet owners.

2. The Granularity of Public Health Warnings (HPAI in Felines)

The debate over Avian Flu (HPAI) transparency highlights a deeper statistical disconnect in how federal agencies communicate biological risks.

• The Public Narrative: FDA communications have heavily targeted raw pet diets, warning consumers of potential HPAI contamination risks.
• The Statistical Reality: According to USDA tracking data covering domestic feline diagnoses since May 2022 (totaling 145 cases), raw-fed cats account for only 4% of diagnosed cases.
• The Missing Data: The remaining 96% of cases represent an information vacuum. Because the FDA has not publicly detailed the dietary profiles (e.g., kibble consumption) or environmental lifestyles (indoor-only vs. outdoor access) of the vast majority of infected cats, independent advocates argue that pet owners are left blind to true systemic vectors. If the vast majority of afflicted felines consumed commercial kibble or had outdoor exposure, focusing regulatory warnings exclusively on raw diets creates a potentially hazardous blind spot for pet safety.

3. Regulatory Response Times

The timeline of the 2022 Citizen Petition underscores structural delays within the CVM. Under standard administrative procedures, federal agencies are given a 180-day window to evaluate and respond to citizen petitions. Taking 1,333 days—more than 3.6 years—to issue a formal denial severely tests the boundaries of administrative accountability. Furthermore, ignoring a subsequent 45-day request for reconsideration for over five months illustrates a growing reluctance to engage with stakeholder communities.

Official Responses and Agency Stance

The response of the federal apparatus to these persistent inquiries has been minimal, highly formalized, and, in many cases, entirely absent.

When the CVM has broken its silence, its replies have often deflected substance in favor of procedural redirection. This was demonstrated during the May and June 2025 exchanges regarding the AAFCO Pet Food Label Modernization project. When asked whether the extensive label updates developed by AAFCO would be officially recognized by the federal government following the dissolution of their cooperative MOU, the CVM’s AskCVM helpfully directed the petitioner to a historical expiration notice. When pressed a second time because the referenced link contained zero information on label modernization, the agency simply doubled down, instructing the inquirer to "refer to our previous response."

This administrative stonewalling leaves consumer advocates with little recourse other than public exposure and persistent follow-ups. While regulated industries maintain structured pathways for communication and lobbying through institutional frameworks, individual pet owners and consumer representatives find themselves navigating an opaque wall of automated deferrals and prolonged silences.

Implications: What This Means for Pet Owners and the Industry

The ongoing breakdown in communication between the FDA and consumer advocates carries significant implications for the future of the pet food marketplace, animal health, and regulatory trust.

1. Erosion of Consumer Trust

When a regulatory agency charged with enforcing federal truth-in-labeling laws refuses to explain why processed meal products are marketed with images of fresh culinary meats, public trust erodes. Pet owners increasingly realize that federal oversight does not actively police every misleading marketing aesthetic on store shelves. This forces consumers to conduct independent research, rely on curated third-party "trusted lists," and second-guess the claims made by major multinational pet food brands.

2. Public Health Vulnerabilities

The silence surrounding avian flu statistics among domestic cats highlights a potentially dangerous operational philosophy in risk communication. If public health messaging is tailored to fit a specific regulatory narrative—such as an ongoing campaign against raw diets—while ignoring 96% of broader epidemiological data, public safety is compromised. Pet owners cannot adequately protect their animals from environmental or dietary pathogens if comprehensive, unbiased data is withheld or ignored by federal health authorities.

3. Regulatory Uncertainty in Label Modernization

The rift between the FDA and AAFCO, compounded by the CVM’s refusal to clarify the status of Pet Food Label Modernization, leaves manufacturers and consumers in limbo. Label modernization efforts are designed to bring greater clarity, better allergen warnings, and more accurate ingredient groupings to pet food packaging. Without clear federal alignment, the industry risks fracturing into inconsistent state-by-state enforcement regimes, making national compliance confusing and consumer comprehension nearly impossible.

4. The Resilience of Independent Advocacy

Despite the institutional hurdles, stonewalling, and multi-year delays, consumer advocates remain steadfast. Organizations like the Association for Truth in Pet Food continue to push for transparency, fund stakeholder representation, and demand that federal watchdogs do the job they were created to perform.

As Susan Thixton emphasizes, despite the FDA’s persistent lack of responsiveness, consumer advocates will continue to ask for answers. In an industry where pets cannot speak for themselves, maintaining relentless external pressure on regulatory bodies remains the primary line of defense for animal health and consumer rights.